Table 2.
Clinical, Laboratory, and Radiological Findings
| Finding | Total (n = 26) | Non-survivors (n = 7) | Survivors (n = 19) | p-value |
|---|---|---|---|---|
| Clinical presentation and physical evaluation | ||||
| Fever, n (%) | 21 (81) | 7 (100) | 14 (74) | 0.2 |
| Cough, n (%) | 16 (62) | 6 (86) | 10 (53) | 0.1 |
| Fever or cough, n (%) | 23 (88) | 7 (100) | 16 (84) | 0.9 |
| Dyspnea, n (%) | 8 (31) | 4 (43) | 4 (21) | 0.2 |
| Gastrointestinal symptoms, n (%) | 6 (23) | 0 (0) | 6 (32) | 0.06 |
| Physical examination | ||||
| Respiratory rate, breaths per minute | 14 (13–18) | 30 (18–33) | 14 (12–15) | <0.01 |
| Oxygen saturation on room air, % | 96 (90–98) | 84 (84–92) | 97 (96–98) | <0.01 |
| Laboratory tests and radiological findings | ||||
| Leukocytes, cells/mm3, median (IQR) | 4,500 (2,940–8,050) | 4,160 (2,930–9,965) | 4,500 (2,883–8,050) | 1.0 |
| Lymphocytes, cells/mm3, median (IQR) | 800 (530–2,000) | 695 (505–825) | 800 (595–2,400) | 0.4 |
| C-reactive protein, mg/L, median (IQR) | 27 (10–92) | 91 (27–195) | 20 (10–67) | 0.03 |
| Procalcitonin, ng/ml, median (IQR) | 0.04 (0.01–0.24) | 1.24 (0.57–1.57) | 0.03(0.01–0.12) | <0.001 |
| D-dimer, ng/ml, median (IQR) | 2,425 (1,390–4,295) | 1,685 (1,075–10,500) | 2,425 (406–4,091) | 0.8 |
| Ferritin, µg/liter, median (IQR) | 984 (195–1243) | 991 (242–1747) | 703 (177–1243) | 0.5 |
| Abnormal chest X-ray, n (%) | 16 (62) | 7 (100) | 9 (47) | <0.01 |
| Clinical diagnosis | ||||
| Pneumonia, n (%) | 17 (66) | 7 (100) | 10 (53) | 0.01 |
| Severe pneumonia, n (%) | 8 (31) | 6 (86) | 2 (11) | <0.001 |
Abbreviation: IQR, interquartile range.